December 14, 2024 10:29 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pushpa 2 stampede: Allu Arjun walks out of jail, actor's lawyer slams delay in release | Donald Trump intends to end 'inconvenient' and 'very costly' Daylight Saving Time | Suchir Balaji: Indian-origin former OpenAI researcher found dead at US apartment | Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days
Merck and Ridgeback’s Molnupiravir medicine demonstrates activity against Omicron variant

Merck and Ridgeback’s Molnupiravir medicine demonstrates activity against Omicron variant

Jan 29, 2022, at 03:49 pm

New Jersey: Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics has announced data from six preclinical studies demonstrating that molnupiravir, an investigational oral antiviral COVID-19 medicine, was active against the SARS-CoV-2 variant Omicron (B1.1.529) in vitro.

Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Jan 06, 2022, at 04:36 am

New Delhi/IBNS: Indian Council for Medical Research (ICMR) has cited 'major safety concerns' for not adding Merck's coronavirus pill, Molnupiravir, to the national treatment protocol.

Indian drugs regulator seeks more info on Merck's Covid-19 pill

Indian drugs regulator seeks more info on Merck's Covid-19 pill

Nov 19, 2021, at 10:15 pm

New Delhi/IBNS: Indian drug regulator CDSCO's expert panel has sought additional data from the companies seeking emergency use authorisation (EUA) for MSD's Covid-19 antiviral medication molnupiravir, media reports said.

UK becomes first country to approve Merck's Covid-19 pill molnupiravir: Report

UK becomes first country to approve Merck's Covid-19 pill molnupiravir: Report

Nov 05, 2021, at 02:34 am

London/IBNS: Britain on Thursday became the first country to approve COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, media reports said.